Sanctuary Advisors LLC Has $1.24 Million Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Sanctuary Advisors LLC boosted its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH) by 11.0% in the 3rd quarter, Holdings Channel.com reports. The firm owned 17,248 shares of the company’s stock after acquiring an additional 1,715 shares during the period. Sanctuary Advisors LLC’s holdings in Prestige Consumer Healthcare were worth $1,244,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds also recently made changes to their positions in the business. Quest Partners LLC raised its position in shares of Prestige Consumer Healthcare by 2,826.7% in the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock valued at $30,000 after buying an additional 424 shares in the last quarter. Northwestern Mutual Wealth Management Co. raised its holdings in shares of Prestige Consumer Healthcare by 562.3% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock worth $35,000 after buying an additional 433 shares in the last quarter. nVerses Capital LLC lifted its position in shares of Prestige Consumer Healthcare by 200.0% during the 3rd quarter. nVerses Capital LLC now owns 600 shares of the company’s stock worth $43,000 after buying an additional 400 shares during the last quarter. Huntington National Bank boosted its stake in Prestige Consumer Healthcare by 39.9% in the third quarter. Huntington National Bank now owns 635 shares of the company’s stock valued at $46,000 after buying an additional 181 shares in the last quarter. Finally, International Assets Investment Management LLC raised its stake in Prestige Consumer Healthcare by 7,112.5% during the third quarter. International Assets Investment Management LLC now owns 1,154 shares of the company’s stock worth $83,000 after acquiring an additional 1,138 shares in the last quarter. 99.95% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on PBH shares. Jefferies Financial Group reissued a “hold” rating and issued a $76.00 price objective (up previously from $70.00) on shares of Prestige Consumer Healthcare in a research note on Tuesday, September 24th. DA Davidson reissued a “buy” rating and set a $95.00 price objective on shares of Prestige Consumer Healthcare in a report on Monday, November 11th. Sidoti cut Prestige Consumer Healthcare from a “buy” rating to a “neutral” rating and set a $90.00 target price for the company. in a report on Monday, December 9th. Raymond James upgraded shares of Prestige Consumer Healthcare to a “moderate buy” rating in a research report on Thursday. Finally, StockNews.com upgraded Prestige Consumer Healthcare from a “hold” rating to a “buy” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat.com, Prestige Consumer Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $85.25.

Insider Buying and Selling at Prestige Consumer Healthcare

In other Prestige Consumer Healthcare news, CEO Ronald M. Lombardi sold 10,875 shares of the stock in a transaction dated Tuesday, November 19th. The shares were sold at an average price of $82.60, for a total value of $898,275.00. Following the completion of the sale, the chief executive officer now owns 320,952 shares in the company, valued at approximately $26,510,635.20. This trade represents a 3.28 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Mary Beth Fritz sold 9,885 shares of the business’s stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $81.97, for a total value of $810,273.45. Following the completion of the transaction, the senior vice president now owns 18,835 shares in the company, valued at $1,543,904.95. The trade was a 34.42 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 38,810 shares of company stock valued at $3,187,300. Corporate insiders own 1.60% of the company’s stock.

Prestige Consumer Healthcare Stock Up 0.1 %

Shares of NYSE PBH opened at $78.72 on Friday. The company has a quick ratio of 2.10, a current ratio of 3.56 and a debt-to-equity ratio of 0.61. The company’s fifty day simple moving average is $79.25 and its 200 day simple moving average is $73.10. The firm has a market cap of $3.89 billion, a PE ratio of 19.15, a P/E/G ratio of 2.32 and a beta of 0.49. Prestige Consumer Healthcare Inc. has a 12-month low of $57.95 and a 12-month high of $86.36.

Prestige Consumer Healthcare (NYSE:PBH) last issued its earnings results on Thursday, November 7th. The company reported $1.09 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $1.09. Prestige Consumer Healthcare had a return on equity of 12.23% and a net margin of 18.54%. The company had revenue of $283.79 million for the quarter, compared to analysts’ expectations of $282.09 million. During the same period last year, the business earned $1.07 EPS. Prestige Consumer Healthcare’s quarterly revenue was down .9% compared to the same quarter last year. As a group, sell-side analysts forecast that Prestige Consumer Healthcare Inc. will post 4.44 earnings per share for the current fiscal year.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.